Literature DB >> 1662676

An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils.

T T Hansel1, I J De Vries, T Iff, S Rihs, M Wandzilak, S Betz, K Blaser, C Walker.   

Abstract

A simple method is described for the isolation of human peripheral blood eosinophils by an immunomagnetic procedure. Superparamagnetic particles were coupled to a monoclonal antibody against CD16, a molecule present on neutrophils but not on eosinophils. A peripheral blood granulocyte preparation, containing neutrophils and eosinophils, was incubated with these anti-CD16 particles. In the magnetic field of a permanent magnet, magnetically labelled neutrophils were then retained on columns with a ferromagnetic matrix. By this negative selection procedure, eosinophils of 99.5% purity were obtained from normal individuals and 99.6% purity from patients with eczema. A comparison was made between the immunomagnetic method and eosinophil isolation after N-formyl-methionyl-leucyl-phenyl-alanine treatment. Even in the case of individuals with very low eosinophil counts, the immunomagnetic method permits the efficient isolation of highly purified and functionally active eosinophils.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662676     DOI: 10.1016/0022-1759(91)90315-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  100 in total

1.  Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release.

Authors:  C I Ezeamuzie; E Philips
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Cysteine protease secreted by Paragonimus westermani attenuates effector functions of human eosinophils stimulated with immunoglobulin G.

Authors:  M H Shin; H Kita; H Y Park; J Y Seoh
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Mitochondria in eosinophils: functional role in apoptosis but not respiration.

Authors:  K K Peachman; D S Lyles; D A Bass
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

4.  Intercellular adhesion molecule-1 on eosinophils is involved in eosinophil protein X release induced by cytokines.

Authors:  S Horie; Y Okubo; M Hossain; T Momose; J Suzuki; M Isobe; M Sekiguchi
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

5.  Peptidoglycan induces mobilization of the surface marker for activation marker CD66b in human neutrophils but not in eosinophils.

Authors:  Eva Mattsson; Terese Persson; Pia Andersson; Jan Rollof; Arne Egesten
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

6.  TLR-7 Stress Signaling in Differentiating and Mature Eosinophils Is Mediated by the Prolyl Isomerase Pin1.

Authors:  Zhong-Jian Shen; Jie Hu; Venkatesh Kashi; Yury A Bochkov; James E Gern; James S Malter
Journal:  J Immunol       Date:  2018-11-05       Impact factor: 5.422

7.  The impact of eotaxin- and IL-5-induced adhesion and transmigration on eosinophil activity markers.

Authors:  E Fernvik; J Lundahl; G Halldén
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

8.  The differential effect of dexamethasone on granulocyte apoptosis involves stabilization of Mcl-1L in neutrophils but not in eosinophils.

Authors:  Kelly L Sivertson; Michael C Seeds; David L Long; Kristina K Peachman; David A Bass
Journal:  Cell Immunol       Date:  2007-06-14       Impact factor: 4.868

9.  Beta2-integrin-mediated adhesion and intracellular Ca2+ release in human eosinophils.

Authors:  Jennifer L Bankers-Fulbright; Kathleen R Bartemes; Gail M Kephart; Hirohito Kita; Scott M O'Grady
Journal:  J Membr Biol       Date:  2009-03-17       Impact factor: 1.843

10.  Human eosinophil chemotaxis and selective in vivo recruitment by sphingosine 1-phosphate.

Authors:  Fiorentina Roviezzo; Francesco Del Galdo; Gianfranco Abbate; Mariarosaria Bucci; Bruno D'Agostino; Edson Antunes; Gianfranco De Dominicis; Luca Parente; Francesco Rossi; Giuseppe Cirino; Raffaele De Palma
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.